In a phase 2 trial of a novel antihypertensive agent, multiple doses lowered plasma angiotensinogen to a greater extent than a single dose, but did not provide further blood pressure lowering, ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

For patients with uncontrolled hypertension already on two or more medications, monthly injections of tonlamarsen (Kardigan) more effectively lowered plasma angiotensinogen (AGT) levels than a single ...

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific renoprotective ...

The use of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in people with congestive heart failure (CHF) and renal dysfunction is poorly studied. Berger and ...

Discover 9 important ibuprofen interactions to avoid. Learn which medications, supplements, foods, and alcohol can cause ...

Results support initiation of Phase 2b clinical trial of tonlamarsen in patients with acute severe hypertension SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.-- (BUSINESS WIRE)--March 28, 2026-- ...

A health explainer details how specific foods and beverages interact with blood pressure therapy, emphasizing safety implications. It outlines interactions between grapefruit and calcium channel ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

Akebia Therapeutics is back in focus after analysts trimmed their fair value estimate from US$5.00 to US$4.40, aligning with updated price targets clustered around US$4.00. These moves reflect how ...

Angioplasty or stenting is a common procedure used to open blocked or narrowed arteries This is a painless procedure that ...

Canada: A recent study published in JAMA Network Open suggests that while hydralazine use may be linked to a slightly higher ...